SCHEMBL11068693

SCHEMBL11068693

N#Cc1cc2sc3ncccc3c2[nH]c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.38
CDK5 Q00535 3/20 0.38
CDK5R1 Q15078 3/20 0.38
CLK1 P49759 2/20 0.38
CLK2 P49760 2/20 0.38
CLK3 P49761 2/20 0.38
DYRK1A Q13627 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
DYRK1B Q9Y463 2/20 0.38
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
PDE5A O76074 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
PTGS1 P23219 1/20 0.36
PDE4A P27815 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11071485 0.80 LRRK2 (0.39) LRRK2CDK5CDK5R1CLK1CLK2
SCHEMBL21560949 0.72 ADORA2A (0.40) CLK1CCNB2CDK1CCNB1CCNB3
SCHEMBL11068415 0.71 KDM4E (0.44) LRRK2CDK5CDK5R1CLK1CLK2
SCHEMBL11072002 0.69 KDM4D (0.43) HPGDLMNAALDH1A1KDM4DLIMK1
SCHEMBL7338498 0.68 PARP1 (0.47) LRRK2CDK5CDK5R1KDM4EHPGD
SCHEMBL11633151 0.68 G6PD (0.40) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL10689563 0.67 DAO (0.59) LRRK2CDK5CDK5R1CLK1CLK2
SCHEMBL30421743 0.67 DAO (0.59) LRRK2KDM4EHPGDPDE3BPDE3A
SCHEMBL10689557 0.67 DAO (0.59) LRRK2KDM4EHPGDPDE3BPDE3A
SCHEMBL11075196 0.67 KDM4E (0.39) LRRK2CDK5CDK5R1CLK1CLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4474786-A CONGESTIVE HEART FAILURE SCHERING CORPORATION (US) 1984-10-02 US disclosed
EP-0102046-A1 Tricyclic lactams, method for making them, pharmaceutical compositions containing them SCHERING CORPORATION (US) 1984-03-07 EP disclosed